Grosse Pointe Shores, Michigan
Presenter
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; IMPROVING VASCULAR CARE QUALITY; FIXING FALSE TESTIMONY; FLAWED PEER REVIEW; FDA IMPROVEMENTS; LEARNING HEALTH SYSTEMS
Presenter
SESSION 113: POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; IMPROVING VASCULAR CARE QUALITY; FIXING FALSE TESTIMONY; FLAWED PEER REVIEW; FDA IMPROVEMENTS; LEARNING HEALTH SYSTEMS
I Was From The Government And I'm Here To Help: FDA Resources To Assure Safe And Effective Medical Devices In Vascular Disease: What Is The LEAF Initiative To Assure That Trials Are Appropriate For FDA Approval
5:35 PM - 5:40 PM
Presenter
SESSION 113: POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
DEBATE: Regulatory Approval Of Novel Vascular Access Devices: When A Randomized Clinical Study Could Help
1:16 PM - 1:23 PM
OUTPATIENT FACILITIES FOR VASCULAR PROCEDURES AND CLINICAL RESEARCH
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
2:01 PM - 2:09 PM
Can Clinical Trials for Regulatory Approval be Performed in the OBL/ASC Setting? Requirements, Opportunities, and Barriers
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
2:01 PM - 2:09 PM
Can Clinical Trials for Regulatory Approval be Performed in the OBL/ASC Setting? Requirements, Opportunities, and Barriers